Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The total number of patients with sarcopenia, i.e. with both low aLMI and reduced HGS, was 16 of 75 (21 %) at baseline (missing HGS data n = 4); the corresponding figures at 6 and 12 months were 24 and 29 %, respectively, with no significant difference between groups over the observation period.Flow chart of participantsBaseline characteristics of all participants and by intervention groupAll patients (n = 79)Group N (n = 26)Group B (n = 28)Group C (n = 25)Age, mean (SD)79 (9)81 (8)80 (9)78 (11)Age, median (range)81 (61 to 96)82 (62 to 93)82 (63 to 94)75 (61 to 96)Gender, female n (%) Women56 (71)19 (73)18 (64)19 (76) Men23 (29)7 (27)10 (36)6 (24)Type of fracture n (%) Femoral neck33 (42)10 (38)12 (43)11 (44) Trochanteric46 (58)16 (62)16 (57)14 (56)Surgical method n (%) Internal fixation69 (87)23 (88)25 (89)21 (84) Arthroplasty10 (13)3 (12)3 (11)4 (16)Time to surgery n (%) Within 24 hours43 (54)13 (16)17 (22)13 (16) > 24 to 48 hours36 (46)13 (16)11 (14)12 (15)ASA 1 to 2 n (%)60 (76)20 (25)22 (28)18 (23)ASA 3 to 4 n (%)19 (24)6 (9)6 (8)7 (8)Body mass,kg mean (SD)63.0 (12.3)61.4 (9.8)66.9 (13.3)60.2 (12.8) Women58.7 (10.0)60.2 (9.8)60.7 (10.0)55.4 (9.8) Men73.3 (11.3)64.7 (9.5)78.2 (11.2)75.4 (8.7)BMI, kg/m2 mean (SD)23.0 (3.0)22.7 (3.4)24.0 (2.9)22.4 (2.6) Women22.8 (3.1)23.0 (3.5)23.9 (3.1)21.7 (2.5) Men23.5 (2.8)21.8 (3.3)24.1 (2.8)24.5 (1.2)FFMI, kg/m2 mean (SD)16.1 (2.0)15.6 (1.9)16.8 (2.0)16.0 (2.0) Women15.3 (1.4)15.0 (1.6)15.9 (1.4)15.1 (1.0) Men18.1 (2.0)17.1 (2.0)18.3 (2.0)18.8 (1.7)FMI, kg/m2 mean (SD)6.9 (2.5)7.1 (2.9)7.2 (2.4)6.4 (2.0) Women7.5 (2.5)8.0 (2.6)8.0 (2.4)6.6 (2.2) Men5.5 (1.8)4.8 (2.4)5.8 (1.7)5.7 (1.1)aLMI, kg/m2 6.2 (0.9)6.0 (0.8)6.5 (0.9)6.2 (1.0) Women5.9 (0.7)5.8 (0.8)6.1 (0.6)5.8 (0.6) Men7.0 (1.0)6.6 (80.8)7.1 (1.0)7.5 (0.9)Handgrip strength, kg, median (range)20 (6 to 64)20 (6 to 63)22 (6 to 64)20 (8 to 58) Women18 (6 to 38)18 (6 to 32)18 (6 to 28)17 (8 to 38) Men36 (20 to 64)24 (20 to 33)45 (28 to 64)40 (23 to 58)EQ-5Dindex mean, (SD)0.85 (0.21)0.84 (0.22)0.84 (0.25)0.88 (0.12)S-IGF-I, μg/L, median, (range)87 (27 to 239)72 (30 to 169)93 (30 to 207)87 (27 to 239)S-IGF-I age matched SD: score−0.6−1.1−0.1−0.8P-Alb g/L, median, (range)34 (26 to 44)34 (27 to 42)34 (26 to 44)34 (26 to 44)B-Hbg g/L, median, (range)124 (90 to 156)124 (97 to 149)128 (103 to 156)119 (90 to 153)S-CRP mg/L, median (range)3 (0 to 257)4 (0 to 136)2 (0 to 253)8 (0 to 257)P-Creatinine μmol/L,median, (range)71 (37 to 174)69 (37 to 136)74 (47 to 118)71 (49 to 174)S-ALAT, μkat/L, median, (range)0.41 (0.10 to 8.82)0.36 (0.10 to 8.82)0.40 (0.12 to 3.02)0.45 (0.19 to 1.57)S-ASAT, μkat/L, median, (range)0.65 (0.22 to 2.42)0.66 (0.23 to 1.61)0.62 (0.35 to 2.42)0.60 (0.22 to 1.60)S-TSH, mE/L, median (range)1.5 (0.1 to 9.3)1.7 (0.4 to 8.5)1.4 (0.8 to 8.5)1.4 (0.4 to 9.3)Group N, received nutritional supplementation, bisphosphonate, calcium and vitamin D3; B, received bisphosphonate, calcium and vitamin D; C, controls, treated with calcium and vitamin D.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were randomized postoperatively to receive liquid supplementation that provided 40 g of protein and 600 kcal daily for six months after the fracture, in addition to bisphosphonates once weekly for 12 months (group N, n = 26), or bisphosphonates alone once weekly for 12 months (group B, n = 28).
Source: Abstract.
The primary purpose of this randomized multicenter trial was to study the effects of combined therapy with bisphosphonate and protein-rich nutritional supplementation after hip fracture on body composition, HGS and HRQoL.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study
Randomised controlled trial · BMC Geriatrics · 2015
Original publication title
Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study
© Flodin et al. 2015
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The catabolic state that follows hip fracture contributes to loss of muscle mass and strength, that is sarcopenia, which impacts functional ability and health-related quality of life. Measures to prevent such long-term postoperative consequences are of important concern. The aim of this study was to evaluate the combined effects of protein-rich nutritional supplementation and bisphosphonate on body composition, handgrip strength and health-related quality of life following hip fracture.
Source: BackgroundAbstract: What methods does the paper describe?
The study included 79 men and women with hip fracture, mean age 79 years (SD 9), without severe cognitive impairment, who were ambulatory and living independently before fracture. Patients were randomized postoperatively to receive liquid supplementation that provided 40 g of protein and 600 kcal daily for six months after the fracture, in addition to bisphosphonates once weekly for 12 months (group N, n = 26), or bisphosphonates alone once weekly for 12 months (group B, n = 28). All patients, including the controls (group C, n = 25) received calcium 1 g and vitamin D3 800 IU daily.
Body composition as measured by dual-energy X-ray absorptiometry (DXA), handgrip strength (HGS) and health-related quality of life (HRQoL) were registered at baseline, six and 12 months postoperatively.
Source: MethodsAbstract: Electronic supplementary material
The online version of this article (doi:10.1186/s12877-015-0144-7) contains supplementary material, which is available to authorized users.
Source: Electronic supplementary materialAbstract: Results
There were no differences among the groups regarding change in fat-free mass index (FFMI), HGS, or HRQoL during the study year. Intra-group analyses showed improvement of HGS between baseline and six months in the N group (P = 0.04). HRQoL decreased during the first year in the C and B groups (P = 0.03 and P = 0.01, respectively) but not in the nutritional supplementation N group (P = 0.22).
Source: ResultsAbstract: Conclusions
Protein-rich nutritional supplementation was unable to preserve FFMI more effectively than vitamin D and calcium alone, or combined with bisphosphonate, in this relatively healthy group of hip fracture patients. However, trends toward positive effects on both HGS and HRQoL were observed following nutritional supplementation.
Source: ConclusionsAuthors’ abstract
Background
The catabolic state that follows hip fracture contributes to loss of muscle mass and strength, that is sarcopenia, which impacts functional ability and health-related quality of life. Measures to prevent such long-term postoperative consequences are of important concern. The aim of this study was to evaluate the combined effects of protein-rich nutritional supplementation and bisphosphonate on body composition, handgrip strength and health-related quality of life following hip fracture.
Methods
The study included 79 men and women with hip fracture, mean age 79 years (SD 9), without severe cognitive impairment, who were ambulatory and living independently before fracture. Patients were randomized postoperatively to receive liquid supplementation that provided 40 g of protein and 600 kcal daily for six months after the fracture, in addition to bisphosphonates once weekly for 12 months (group N, n = 26), or bisphosphonates alone once weekly for 12 months (group B, n = 28). All patients, including the controls (group C, n = 25) received calcium 1 g and vitamin D3 800 IU daily.
Body composition as measured by dual-energy X-ray absorptiometry (DXA), handgrip strength (HGS) and health-related quality of life (HRQoL) were registered at baseline, six and 12 months postoperatively.
Results
There were no differences among the groups regarding change in fat-free mass index (FFMI), HGS, or HRQoL during the study year. Intra-group analyses showed improvement of HGS between baseline and six months in the N group (P = 0.04). HRQoL decreased during the first year in the C and B groups (P = 0.03 and P = 0.01, respectively) but not in the nutritional supplementation N group (P = 0.22).
Conclusions
Protein-rich nutritional supplementation was unable to preserve FFMI more effectively than vitamin D and calcium alone, or combined with bisphosphonate, in this relatively healthy group of hip fracture patients. However, trends toward positive effects on both HGS and HRQoL were observed following nutritional supplementation.
Trial registration
Clinicaltrials.gov NCT01950169 (Date of registration 23 Sept 2013).
Electronic supplementary material
The online version of this article (doi:10.1186/s12877-015-0144-7) contains supplementary material, which is available to authorized users.
Publication and source details
Original title: Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study
Lena Flodin; Tommy Cederholm; Maria Sääf; Eva Samnegård; Wilhelmina Ekström; Amer N. Al-Ani; Margareta Hedström
BMC Geriatrics · 2015
© Flodin et al. 2015https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:03:44.578679+00:00
DOI: 10.1186/s12877-015-0144-7 · PMC4647612